Cobourn Steven P. 4
4 · NextCure, Inc. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Cobourn Steven P.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-28+78,200→ 78,200 totalExercise: $41.76Exp: 2030-02-27→ Common Stock (78,200 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on February 28, 2021. The remainder vests in 36 monthly installments beginning on March 28, 2021.